Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Instem PLC - Staffordshire, England-based provider of IT services to life sciences market - Takeover offer from funds managed by Archimed SAS is declared final and won’t be increased. Back in August, Instem agreed to an offer from Archimed of 833 pence per share in cash. This values Instem at £203 million in total. Archimed is a specialist healthcare investor registered in Lyon, France, with offices also in New York and Singapore. The court and general meetings to approval the takeover are scheduled for Thursday next week.
Current stock price: 743.00, down 9.1% in London on Friday
12-month change: up 25%
Copyright 2023 Alliance News Ltd. All Rights Reserved.